Quantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastoma.
Deistung A, Schweser F, Wiestler B, Abello M, Roethke M, Sahm F, Wick W, Nagel AM, Heiland S, Schlemmer HP, Bendszus M, Reichenbach JR, Radbruch A.
Deistung A, et al. Among authors: radbruch a.
PLoS One. 2013;8(3):e57924. doi: 10.1371/journal.pone.0057924. Epub 2013 Mar 21.
PLoS One. 2013.
PMID: 23555565
Free PMC article.
Clinical Trial.